Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor

Diabetes Research and Clinical Practice

Volumn 109, Issue 2, 2015, Pages e8-e10

  Yamaguchi, Suguru ^a   Ikejima, Midori ^a   Furukawa, Asami ^a   Abe, Masanori ^a   Nakazaki, Mitsuhiro ^a   Ishihara, Hisamitsu ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DPP 4 inhibitor; Hypoglycemia; Octreotide; Sulfonylurea

Indexed keywords

C PEPTIDE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOREACTIVE INSULIN; INSULIN; OCTREOTIDE; SULFONYLUREA; VILDAGLIPTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ENZYME INHIBITOR; GASTROINTESTINAL AGENT; GLUCOSE BLOOD LEVEL; SULFONYLUREA DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; DRUG MISUSE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC COMA; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN RELEASE; JAPANESE (PEOPLE); MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; BLOOD; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; METABOLISM;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENZYME INHIBITORS; GASTROINTESTINAL AGENTS; HUMANS; HYPOGLYCEMIA; MALE; OCTREOTIDE; SULFONYLUREA COMPOUNDS;

EID: 84937972634     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.05.008     Document Type: Article

References (8)

1. Boyle P.J., Justice K., Krentz A.J., Nagy R.J., Schade D.S. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993, 76:752-756.
2. Dougherty P.P., Klein-Schwartz W. Octreotide's role in the management of sulfonylurea-induced hypoglycemia. J Med Toxicol 2010, 6:199-206.
3. Lajara R., Aguilar R., Hehnke U., Woerle H.J., von Eynatten M. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials. Clin Ther 2014, 36:1595-1605.
4. Sato D., Sato Y., Masuda S., Kimura H. Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan. Int J Clin Pharm 2012, 34:917-924.
5. Green R.S., Palatnick W. Effectiveness of octreotide in a case of refractory sulfonylurea-induced hypoglycemia. J Emerg Med 2003, 25(3):283-287.
6. Gonzalez R.R., Zweig S., Rao J., Block R., Greene L.W. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure. Endocr Pract 2007, 13:417-423.
7. Glatstein M., Scolnik D., Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol (Phila) 2012, 50:795-804.
8. Dougherty P.P., Lee S.C., Lung D., Klein-Schwartz W. Evaluation of the use and safety of octreotide as antidotal therapy for sulfonylurea overdose in children. Pediatr Emerg Care 2013, 29:292-295.